Cresset Asset Management’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$849K Buy
10,858
+41
+0.4% +$3.21K ﹤0.01% 832
2025
Q1
$784K Sell
10,817
-6,913
-39% -$501K ﹤0.01% 861
2024
Q4
$1.31M Sell
17,730
-30,481
-63% -$2.26M 0.01% 680
2024
Q3
$3.18M Buy
48,211
+1,754
+4% +$116K 0.01% 587
2024
Q2
$4.29M Buy
46,457
+3,878
+9% +$358K 0.02% 452
2024
Q1
$4.07M Buy
42,579
+14,948
+54% +$1.43M 0.02% 409
2023
Q4
$2.11M Sell
27,631
-9,599
-26% -$732K 0.01% 556
2023
Q3
$2.58M Sell
37,230
-6,702
-15% -$464K 0.01% 440
2023
Q2
$4.14M Buy
43,932
+36,434
+486% +$3.44M 0.01% 353
2023
Q1
$620K Sell
7,498
-2,304
-24% -$191K 0.01% 438
2022
Q4
$270K Buy
9,802
+584
+6% +$16.1K ﹤0.01% 559
2022
Q3
$762K Sell
9,218
-1,638
-15% -$135K 0.01% 411
2022
Q2
$1M Sell
10,856
-2,473
-19% -$228K 0.01% 379
2022
Q1
$1.57M Sell
13,329
-3,013
-18% -$354K 0.02% 298
2021
Q4
$2.12M Buy
16,342
+1,233
+8% +$160K 0.02% 287
2021
Q3
$1.71M Buy
15,109
+539
+4% +$61K 0.02% 257
2021
Q2
$1.51M Buy
14,570
+9,019
+162% +$934K 0.02% 257
2021
Q1
$465K Buy
5,551
+2,665
+92% +$223K 0.01% 504
2020
Q4
$263K Sell
2,886
-5,823
-67% -$531K ﹤0.01% 602
2020
Q3
$695K Buy
8,709
+196
+2% +$15.6K 0.01% 300
2020
Q2
$588K Buy
8,513
+2,513
+42% +$174K 0.01% 311
2020
Q1
$377K Buy
6,000
+798
+15% +$50.1K 0.01% 341
2019
Q4
$405K Sell
5,202
-543
-9% -$42.3K 0.01% 347
2019
Q3
$421K Buy
+5,745
New +$421K 0.01% 299
2019
Q2
Sell
-7,836
Closed -$500K 852
2019
Q1
$500K Buy
+7,836
New +$500K 0.02% 189